Strides Shasun agrees to settle regulatory, general claims on Agila transaction

04 Nov 2016 Evaluate

Pharma major Strides Shasun has agreed to settle regulatory and general claims with the US-based Mylan on Agila transaction. Both the companies have now agreed on a full and final settlement of the warranty and indemnity claims. After payment to Mylan, the company will receive approximately $30 million from Regulatory escrow.

Strides Shasun (formerly known as Strides Arcolab) is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.



Strides Pharma Scien Share Price

887.10 -3.30 (-0.37%)
10-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.25
Dr. Reddys Lab 1251.10
Cipla 1489.15
Zydus Lifesciences 923.70
Lupin 2055.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×